High levels of acetaldehyde in nonalcoholic liver injury after threonine or ethanol administration

Authors

  • Xiao-Li Ma,

    1. Section of Liver Disease and Nutrition and Alcohol Research and Treatment Center, Bronx Veterans Affairs Medical Center and Mount Sinai School of Medicine, New York 10468
    Search for more papers by this author
  • Enrique Baraona,

    1. Section of Liver Disease and Nutrition and Alcohol Research and Treatment Center, Bronx Veterans Affairs Medical Center and Mount Sinai School of Medicine, New York 10468
    Search for more papers by this author
  • Rolando Hernández-Muñoz,

    1. Section of Liver Disease and Nutrition and Alcohol Research and Treatment Center, Bronx Veterans Affairs Medical Center and Mount Sinai School of Medicine, New York 10468
    Search for more papers by this author
    • International Fogarty Fellow (National Institutes of Health).

  • Charles S. Lieber M.D.

    Corresponding author
    1. Section of Liver Disease and Nutrition and Alcohol Research and Treatment Center, Bronx Veterans Affairs Medical Center and Mount Sinai School of Medicine, New York 10468
    • Alcohol Research and Treatment Center, Veterans Affairs Medical Center, 130 West Kingsbridge Road, Bronx, New York 10468
    Search for more papers by this author

Abstract

Acetaldehyde, a product of ethanol oxidation which forms adducts with proteins, has been incriminated in the pathogenesis of alcoholic liver injury. High serum antibody titers against acetaldehyde-protein adducts have been found not only in alcoholics but also in patients with nonalcoholic liver disease, suggesting a contribution of acetaldehyde derived from sources other than exogenous ethanol. To investigate the effect of liver injury on the removal and the production of acetaldehyde, we produced fibrosis and cirrhosis (by chronic administration of carbon tetrachloride) and fatty liver (with very small doses of dimethylnitrosamine) in rats. Endogenous blood acetaldehyde levels increased by 38% in rats with severe liver injury (p < 0.005), but not significantly in rats with fatty liver. However, an i.v. load of threonine (a physiological source of acetaldehyde), in amounts equivalent to the daily intake of this amino acid, increased blood and hepatic acetaldehyde levels in the rats with both types of liver injury more than in controls. Threonine dehydrogenase and dehydratase activities, involved in the major pathways for threonine degradation in mitochondria and cytosol, respectively, were markedly decreased in rats with liver injury with a resulting increase in hepatic threonine concentration. Moreover, the threonine aldolase activity, which splits threonine into glycine and acetaldehyde, remained unaffected or even slightly increased. Liver injury was also associated with impaired mitochondrial functions, including a 10 to 23% decrease in acetaldehyde oxidation (depending upon the severity of the lesions). As a consequence, administration of ethanol (an exogenous source of acetaldehyde) resulted in striking elevations in the levels of acetaldehyde in carbon tetrachloride-treated rats. Thus, liver injury promotes the accumulation of acetaldehyde from either physiological sources or from ethanol by decreasing acetaldehyde oxidation and by enhancing its production from threonine.

Ancillary